世界の分子診断・NAT市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Molecular Diagnostics and NAT Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3890 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、分子診断・NATのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（増幅技術、増幅遺伝子検出技術、DNA・オリゴヌクレオチドマイクロアレイ、遺伝子配列決定）、用途別市場規模（病院・クリニック、研究所、診断センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・分子診断・NATの市場動向 ・企業の競争状況、市場シェア ・分子診断・NATの種類別市場規模（増幅技術、増幅遺伝子検出技術、DNA・オリゴヌクレオチドマイクロアレイ、遺伝子配列決定） ・分子診断・NATの用途別市場規模（病院・クリニック、研究所、診断センター） ・分子診断・NATの北米市場規模2016-2027（アメリカ、カナダ） ・分子診断・NATのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・分子診断・NATのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・分子診断・NATの中南米市場規模2016-2027（メキシコ、ブラジル） ・分子診断・NATの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、Abbott、BD、Biomerieux、Qiagen、Thermo Fisher Scientific、Agilent、GenMark、Siemens Healthcare、AutoGenomics） ・結論

Molecular diagnostics is the application of medical and microbiological technologies to the medical imaging science, in order to analyze biological markers present in the proteome and genome, which also includes the study of how an individual express his/her genes as proteins. The is an important diagnostic and patient monitoring technique, which not only diagnose the disease but also access the risks involved in treatment and suggest suitable therapies for the patients. Nucleic acid test, or nucleic acid amplification test (NAT/NAAT) is another molecular technology used in identification of a bacterium or virus. NAT comprises of all the tests and technologies used to identify genetic material of infecting virus or organism.
At present, the North American region is the most prominent market, owing to extensive diagnostic practices and R&D. However, Asia-Pacific and some countries in RoW region are expected to show very lucrative growth in the upcoming period, owing to enhanced awareness and growth in research and diagnostic technologies.

Market Analysis and Insights: Global Molecular Diagnostics and NAT Market
The global Molecular Diagnostics and NAT market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Molecular Diagnostics and NAT market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Molecular Diagnostics and NAT market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Molecular Diagnostics and NAT market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Molecular Diagnostics and NAT market.

Global Molecular Diagnostics and NAT Scope and Market Size
Molecular Diagnostics and NAT market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Molecular Diagnostics and NAT market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Amplification Technologies
Amplified Gene Detection Technologies
DNA And Oligonucleotide Microarrays
Gene Sequencing

Segment by Application
Hospitals and Clinics
Research Institutes
Diagnostic Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
Abbott
BD
Biomerieux
Qiagen
Thermo Fisher Scientific
Agilent
GenMark
Siemens Healthcare

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnostics and NAT Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Amplification Technologies
1.2.3 Amplified Gene Detection Technologies
1.2.4 DNA And Oligonucleotide Microarrays
1.2.5 Gene Sequencing
1.3 Market by Application
1.3.1 Global Molecular Diagnostics and NAT Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals and Clinics
1.3.3 Research Institutes
1.3.4 Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Molecular Diagnostics and NAT Market Perspective (2016-2027)
2.2 Molecular Diagnostics and NAT Growth Trends by Regions
2.2.1 Molecular Diagnostics and NAT Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Molecular Diagnostics and NAT Historic Market Share by Regions (2016-2021)
2.2.3 Molecular Diagnostics and NAT Forecasted Market Size by Regions (2022-2027)
2.3 Molecular Diagnostics and NAT Industry Dynamic
2.3.1 Molecular Diagnostics and NAT Market Trends
2.3.2 Molecular Diagnostics and NAT Market Drivers
2.3.3 Molecular Diagnostics and NAT Market Challenges
2.3.4 Molecular Diagnostics and NAT Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnostics and NAT Players by Revenue
3.1.1 Global Top Molecular Diagnostics and NAT Players by Revenue (2016-2021)
3.1.2 Global Molecular Diagnostics and NAT Revenue Market Share by Players (2016-2021)
3.2 Global Molecular Diagnostics and NAT Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnostics and NAT Revenue
3.4 Global Molecular Diagnostics and NAT Market Concentration Ratio
3.4.1 Global Molecular Diagnostics and NAT Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics and NAT Revenue in 2020
3.5 Molecular Diagnostics and NAT Key Players Head office and Area Served
3.6 Key Players Molecular Diagnostics and NAT Product Solution and Service
3.7 Date of Enter into Molecular Diagnostics and NAT Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Molecular Diagnostics and NAT Breakdown Data by Type
4.1 Global Molecular Diagnostics and NAT Historic Market Size by Type (2016-2021)
4.2 Global Molecular Diagnostics and NAT Forecasted Market Size by Type (2022-2027)

5 Molecular Diagnostics and NAT Breakdown Data by Application
5.1 Global Molecular Diagnostics and NAT Historic Market Size by Application (2016-2021)
5.2 Global Molecular Diagnostics and NAT Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Molecular Diagnostics and NAT Market Size (2016-2027)
6.2 North America Molecular Diagnostics and NAT Market Size by Type
6.2.1 North America Molecular Diagnostics and NAT Market Size by Type (2016-2021)
6.2.2 North America Molecular Diagnostics and NAT Market Size by Type (2022-2027)
6.2.3 North America Molecular Diagnostics and NAT Market Size by Type (2016-2027)
6.3 North America Molecular Diagnostics and NAT Market Size by Application
6.3.1 North America Molecular Diagnostics and NAT Market Size by Application (2016-2021)
6.3.2 North America Molecular Diagnostics and NAT Market Size by Application (2022-2027)
6.3.3 North America Molecular Diagnostics and NAT Market Size by Application (2016-2027)
6.4 North America Molecular Diagnostics and NAT Market Size by Country
6.4.1 North America Molecular Diagnostics and NAT Market Size by Country (2016-2021)
6.4.2 North America Molecular Diagnostics and NAT Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Molecular Diagnostics and NAT Market Size (2016-2027)
7.2 Europe Molecular Diagnostics and NAT Market Size by Type
7.2.1 Europe Molecular Diagnostics and NAT Market Size by Type (2016-2021)
7.2.2 Europe Molecular Diagnostics and NAT Market Size by Type (2022-2027)
7.2.3 Europe Molecular Diagnostics and NAT Market Size by Type (2016-2027)
7.3 Europe Molecular Diagnostics and NAT Market Size by Application
7.3.1 Europe Molecular Diagnostics and NAT Market Size by Application (2016-2021)
7.3.2 Europe Molecular Diagnostics and NAT Market Size by Application (2022-2027)
7.3.3 Europe Molecular Diagnostics and NAT Market Size by Application (2016-2027)
7.4 Europe Molecular Diagnostics and NAT Market Size by Country
7.4.1 Europe Molecular Diagnostics and NAT Market Size by Country (2016-2021)
7.4.2 Europe Molecular Diagnostics and NAT Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnostics and NAT Market Size (2016-2027)
8.2 Asia-Pacific Molecular Diagnostics and NAT Market Size by Type
8.2.1 Asia-Pacific Molecular Diagnostics and NAT Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Molecular Diagnostics and NAT Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Molecular Diagnostics and NAT Market Size by Type (2016-2027)
8.3 Asia-Pacific Molecular Diagnostics and NAT Market Size by Application
8.3.1 Asia-Pacific Molecular Diagnostics and NAT Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Molecular Diagnostics and NAT Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Molecular Diagnostics and NAT Market Size by Application (2016-2027)
8.4 Asia-Pacific Molecular Diagnostics and NAT Market Size by Region
8.4.1 Asia-Pacific Molecular Diagnostics and NAT Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Molecular Diagnostics and NAT Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Molecular Diagnostics and NAT Market Size (2016-2027)
9.2 Latin America Molecular Diagnostics and NAT Market Size by Type
9.2.1 Latin America Molecular Diagnostics and NAT Market Size by Type (2016-2021)
9.2.2 Latin America Molecular Diagnostics and NAT Market Size by Type (2022-2027)
9.2.3 Latin America Molecular Diagnostics and NAT Market Size by Type (2016-2027)
9.3 Latin America Molecular Diagnostics and NAT Market Size by Application
9.3.1 Latin America Molecular Diagnostics and NAT Market Size by Application (2016-2021)
9.3.2 Latin America Molecular Diagnostics and NAT Market Size by Application (2022-2027)
9.3.3 Latin America Molecular Diagnostics and NAT Market Size by Application (2016-2027)
9.4 Latin America Molecular Diagnostics and NAT Market Size by Country
9.4.1 Latin America Molecular Diagnostics and NAT Market Size by Country (2016-2021)
9.4.2 Latin America Molecular Diagnostics and NAT Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnostics and NAT Market Size (2016-2027)
10.2 Middle East & Africa Molecular Diagnostics and NAT Market Size by Type
10.2.1 Middle East & Africa Molecular Diagnostics and NAT Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Molecular Diagnostics and NAT Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Molecular Diagnostics and NAT Market Size by Type (2016-2027)
10.3 Middle East & Africa Molecular Diagnostics and NAT Market Size by Application
10.3.1 Middle East & Africa Molecular Diagnostics and NAT Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Molecular Diagnostics and NAT Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Molecular Diagnostics and NAT Market Size by Application (2016-2027)
10.4 Middle East & Africa Molecular Diagnostics and NAT Market Size by Country
10.4.1 Middle East & Africa Molecular Diagnostics and NAT Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Molecular Diagnostics and NAT Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Molecular Diagnostics and NAT Introduction
11.1.4 Roche Revenue in Molecular Diagnostics and NAT Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Molecular Diagnostics and NAT Introduction
11.2.4 Abbott Revenue in Molecular Diagnostics and NAT Business (2016-2021)
11.2.5 Abbott Recent Development
11.3 BD
11.3.1 BD Company Details
11.3.2 BD Business Overview
11.3.3 BD Molecular Diagnostics and NAT Introduction
11.3.4 BD Revenue in Molecular Diagnostics and NAT Business (2016-2021)
11.3.5 BD Recent Development
11.4 Biomerieux
11.4.1 Biomerieux Company Details
11.4.2 Biomerieux Business Overview
11.4.3 Biomerieux Molecular Diagnostics and NAT Introduction
11.4.4 Biomerieux Revenue in Molecular Diagnostics and NAT Business (2016-2021)
11.4.5 Biomerieux Recent Development
11.5 Qiagen
11.5.1 Qiagen Company Details
11.5.2 Qiagen Business Overview
11.5.3 Qiagen Molecular Diagnostics and NAT Introduction
11.5.4 Qiagen Revenue in Molecular Diagnostics and NAT Business (2016-2021)
11.5.5 Qiagen Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Molecular Diagnostics and NAT Introduction
11.6.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics and NAT Business (2016-2021)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Agilent
11.7.1 Agilent Company Details
11.7.2 Agilent Business Overview
11.7.3 Agilent Molecular Diagnostics and NAT Introduction
11.7.4 Agilent Revenue in Molecular Diagnostics and NAT Business (2016-2021)
11.7.5 Agilent Recent Development
11.8 GenMark
11.8.1 GenMark Company Details
11.8.2 GenMark Business Overview
11.8.3 GenMark Molecular Diagnostics and NAT Introduction
11.8.4 GenMark Revenue in Molecular Diagnostics and NAT Business (2016-2021)
11.8.5 GenMark Recent Development
11.9 Siemens Healthcare
11.9.1 Siemens Healthcare Company Details
11.9.2 Siemens Healthcare Business Overview
11.9.3 Siemens Healthcare Molecular Diagnostics and NAT Introduction
11.9.4 Siemens Healthcare Revenue in Molecular Diagnostics and NAT Business (2016-2021)
11.9.5 Siemens Healthcare Recent Development
11.10 AutoGenomics
11.10.1 AutoGenomics Company Details
11.10.2 AutoGenomics Business Overview
11.10.3 AutoGenomics Molecular Diagnostics and NAT Introduction
11.10.4 AutoGenomics Revenue in Molecular Diagnostics and NAT Business (2016-2021)
11.10.5 AutoGenomics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Molecular Diagnostics and NAT Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Amplification Technologies
Table 3. Key Players of Amplified Gene Detection Technologies
Table 4. Key Players of DNA And Oligonucleotide Microarrays
Table 5. Key Players of Gene Sequencing
Table 6. Global Molecular Diagnostics and NAT Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Molecular Diagnostics and NAT Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Molecular Diagnostics and NAT Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Molecular Diagnostics and NAT Market Share by Regions (2016-2021)
Table 10. Global Molecular Diagnostics and NAT Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Molecular Diagnostics and NAT Market Share by Regions (2022-2027)
Table 12. Molecular Diagnostics and NAT Market Trends
Table 13. Molecular Diagnostics and NAT Market Drivers
Table 14. Molecular Diagnostics and NAT Market Challenges
Table 15. Molecular Diagnostics and NAT Market Restraints
Table 16. Global Molecular Diagnostics and NAT Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Molecular Diagnostics and NAT Market Share by Players (2016-2021)
Table 18. Global Top Molecular Diagnostics and NAT Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnostics and NAT as of 2020)
Table 19. Ranking of Global Top Molecular Diagnostics and NAT Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Molecular Diagnostics and NAT Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Molecular Diagnostics and NAT Product Solution and Service
Table 23. Date of Enter into Molecular Diagnostics and NAT Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Molecular Diagnostics and NAT Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Molecular Diagnostics and NAT Revenue Market Share by Type (2016-2021)
Table 27. Global Molecular Diagnostics and NAT Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Molecular Diagnostics and NAT Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Molecular Diagnostics and NAT Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Molecular Diagnostics and NAT Revenue Market Share by Application (2016-2021)
Table 31. Global Molecular Diagnostics and NAT Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Molecular Diagnostics and NAT Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Molecular Diagnostics and NAT Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Molecular Diagnostics and NAT Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Molecular Diagnostics and NAT Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Molecular Diagnostics and NAT Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Molecular Diagnostics and NAT Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Molecular Diagnostics and NAT Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Molecular Diagnostics and NAT Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Molecular Diagnostics and NAT Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Molecular Diagnostics and NAT Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Molecular Diagnostics and NAT Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Molecular Diagnostics and NAT Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Molecular Diagnostics and NAT Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Molecular Diagnostics and NAT Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Molecular Diagnostics and NAT Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Molecular Diagnostics and NAT Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Molecular Diagnostics and NAT Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Molecular Diagnostics and NAT Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Molecular Diagnostics and NAT Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Molecular Diagnostics and NAT Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Molecular Diagnostics and NAT Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Molecular Diagnostics and NAT Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Molecular Diagnostics and NAT Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Molecular Diagnostics and NAT Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Molecular Diagnostics and NAT Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Molecular Diagnostics and NAT Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Molecular Diagnostics and NAT Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Molecular Diagnostics and NAT Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Molecular Diagnostics and NAT Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Molecular Diagnostics and NAT Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Molecular Diagnostics and NAT Market Size by Country (2022-2027) & (US$ Million)
Table 63. Roche Company Details
Table 64. Roche Business Overview
Table 65. Roche Molecular Diagnostics and NAT Product
Table 66. Roche Revenue in Molecular Diagnostics and NAT Business (2016-2021) & (US$ Million)
Table 67. Roche Recent Development
Table 68. Abbott Company Details
Table 69. Abbott Business Overview
Table 70. Abbott Molecular Diagnostics and NAT Product
Table 71. Abbott Revenue in Molecular Diagnostics and NAT Business (2016-2021) & (US$ Million)
Table 72. Abbott Recent Development
Table 73. BD Company Details
Table 74. BD Business Overview
Table 75. BD Molecular Diagnostics and NAT Product
Table 76. BD Revenue in Molecular Diagnostics and NAT Business (2016-2021) & (US$ Million)
Table 77. BD Recent Development
Table 78. Biomerieux Company Details
Table 79. Biomerieux Business Overview
Table 80. Biomerieux Molecular Diagnostics and NAT Product
Table 81. Biomerieux Revenue in Molecular Diagnostics and NAT Business (2016-2021) & (US$ Million)
Table 82. Biomerieux Recent Development
Table 83. Qiagen Company Details
Table 84. Qiagen Business Overview
Table 85. Qiagen Molecular Diagnostics and NAT Product
Table 86. Qiagen Revenue in Molecular Diagnostics and NAT Business (2016-2021) & (US$ Million)
Table 87. Qiagen Recent Development
Table 88. Thermo Fisher Scientific Company Details
Table 89. Thermo Fisher Scientific Business Overview
Table 90. Thermo Fisher Scientific Molecular Diagnostics and NAT Product
Table 91. Thermo Fisher Scientific Revenue in Molecular Diagnostics and NAT Business (2016-2021) & (US$ Million)
Table 92. Thermo Fisher Scientific Recent Development
Table 93. Agilent Company Details
Table 94. Agilent Business Overview
Table 95. Agilent Molecular Diagnostics and NAT Product
Table 96. Agilent Revenue in Molecular Diagnostics and NAT Business (2016-2021) & (US$ Million)
Table 97. Agilent Recent Development
Table 98. GenMark Company Details
Table 99. GenMark Business Overview
Table 100. GenMark Revenue in Molecular Diagnostics and NAT Business (2016-2021) & (US$ Million)
Table 101. GenMark Recent Development
Table 102. Siemens Healthcare Company Details
Table 103. Siemens Healthcare Business Overview
Table 104. Siemens Healthcare Molecular Diagnostics and NAT Product
Table 105. Siemens Healthcare Revenue in Molecular Diagnostics and NAT Business (2016-2021) & (US$ Million)
Table 106. Siemens Healthcare Recent Development
Table 107. AutoGenomics Company Details
Table 108. AutoGenomics Business Overview
Table 109. AutoGenomics Molecular Diagnostics and NAT Product
Table 110. AutoGenomics Revenue in Molecular Diagnostics and NAT Business (2016-2021) & (US$ Million)
Table 111. AutoGenomics Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Diagnostics and NAT Market Share by Type: 2020 VS 2027
Figure 2. Amplification Technologies Features
Figure 3. Amplified Gene Detection Technologies Features
Figure 4. DNA And Oligonucleotide Microarrays Features
Figure 5. Gene Sequencing Features
Figure 6. Global Molecular Diagnostics and NAT Market Share by Application: 2020 VS 2027
Figure 7. Hospitals and Clinics Case Studies
Figure 8. Research Institutes Case Studies
Figure 9. Diagnostic Centers Case Studies
Figure 10. Molecular Diagnostics and NAT Report Years Considered
Figure 11. Global Molecular Diagnostics and NAT Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Molecular Diagnostics and NAT Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Molecular Diagnostics and NAT Market Share by Regions: 2020 VS 2027
Figure 14. Global Molecular Diagnostics and NAT Market Share by Regions (2022-2027)
Figure 15. Global Molecular Diagnostics and NAT Market Share by Players in 2020
Figure 16. Global Top Molecular Diagnostics and NAT Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnostics and NAT as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Molecular Diagnostics and NAT Revenue in 2020
Figure 18. Global Molecular Diagnostics and NAT Revenue Market Share by Type (2016-2021)
Figure 19. Global Molecular Diagnostics and NAT Revenue Market Share by Type (2022-2027)
Figure 20. North America Molecular Diagnostics and NAT Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Molecular Diagnostics and NAT Market Share by Type (2016-2027)
Figure 22. North America Molecular Diagnostics and NAT Market Share by Application (2016-2027)
Figure 23. North America Molecular Diagnostics and NAT Market Share by Country (2016-2027)
Figure 24. United States Molecular Diagnostics and NAT Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Molecular Diagnostics and NAT Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Molecular Diagnostics and NAT Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Molecular Diagnostics and NAT Market Share by Type (2016-2027)
Figure 28. Europe Molecular Diagnostics and NAT Market Share by Application (2016-2027)
Figure 29. Europe Molecular Diagnostics and NAT Market Share by Country (2016-2027)
Figure 30. Germany Molecular Diagnostics and NAT Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Molecular Diagnostics and NAT Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Molecular Diagnostics and NAT Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Molecular Diagnostics and NAT Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Molecular Diagnostics and NAT Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Molecular Diagnostics and NAT Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Molecular Diagnostics and NAT Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Molecular Diagnostics and NAT Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Molecular Diagnostics and NAT Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Molecular Diagnostics and NAT Market Share by Region (2016-2027)
Figure 40. China Molecular Diagnostics and NAT Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Molecular Diagnostics and NAT Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Molecular Diagnostics and NAT Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Molecular Diagnostics and NAT Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Molecular Diagnostics and NAT Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Molecular Diagnostics and NAT Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Molecular Diagnostics and NAT Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Molecular Diagnostics and NAT Market Share by Type (2016-2027)
Figure 48. Latin America Molecular Diagnostics and NAT Market Share by Application (2016-2027)
Figure 49. Latin America Molecular Diagnostics and NAT Market Share by Country (2016-2027)
Figure 50. Mexico Molecular Diagnostics and NAT Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Molecular Diagnostics and NAT Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Molecular Diagnostics and NAT Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Molecular Diagnostics and NAT Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Molecular Diagnostics and NAT Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Molecular Diagnostics and NAT Market Share by Country (2016-2027)
Figure 56. Turkey Molecular Diagnostics and NAT Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Molecular Diagnostics and NAT Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Molecular Diagnostics and NAT Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Roche Revenue Growth Rate in Molecular Diagnostics and NAT Business (2016-2021)
Figure 60. Abbott Revenue Growth Rate in Molecular Diagnostics and NAT Business (2016-2021)
Figure 61. BD Revenue Growth Rate in Molecular Diagnostics and NAT Business (2016-2021)
Figure 62. Biomerieux Revenue Growth Rate in Molecular Diagnostics and NAT Business (2016-2021)
Figure 63. Qiagen Revenue Growth Rate in Molecular Diagnostics and NAT Business (2016-2021)
Figure 64. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics and NAT Business (2016-2021)
Figure 65. Agilent Revenue Growth Rate in Molecular Diagnostics and NAT Business (2016-2021)
Figure 66. GenMark Revenue Growth Rate in Molecular Diagnostics and NAT Business (2016-2021)
Figure 67. Siemens Healthcare Revenue Growth Rate in Molecular Diagnostics and NAT Business (2016-2021)
Figure 68. AutoGenomics Revenue Growth Rate in Molecular Diagnostics and NAT Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---